WEST Pharmaceutical ($WST) filed a Regulation FD disclosure (Item 7.01) on 2026-02-12, incorporating Item…
Filed with the SEC on · Summarized by InvestorsBot
WEST Pharmaceutical ($WST) filed a Regulation FD disclosure (Item 7.01) on 2026-02-12, incorporating Item 2.02 (Results of Operations & Financial Condition). 📢 Presentation attached as Exhibit 99.2 and available on westpharma.com. #RegulationFD #SEC #pharma
The report and exhibits (including Exhibit 99.2) are furnished — not “filed” — under the Exchange Act, so they're not subject to Section 18 liabilities and won’t be incorporated by reference into other filings unless expressly stated. 🧾 $WST #investing #SEC
Investors: presentation used on the call is posted on the Company’s Investors page (Exhibit 99.2). See Item 2.02 for the detailed Results of Operations & Financial Condition. Review for operational/financial updates. 📈 $WST #earnings #pharma